AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

Vildagliptin And Metformin Hydrochloride

11 registrations across 2 African markets— 11 active

Markets with Vildagliptin And Metformin Hydrochloride

Recent registrations

Brand / ProductMarketHolderStatusExpires
VIGLIPTIN -M 1000MG Tablet
Film-Coated Tablet
🇰🇪KenyaDawa LTDactiveSept 2026
VIGLIPTIN -M 850MG Tablet
Film-Coated Tablet
🇰🇪KenyaDAWA LIMITEDactiveSept 2026
GalvusMet 50/1000
Tablets
🇹🇿TanzaniaNVS Kenya Limitedactive
VILDARIL M 50/500
Film Coated Tablet
🇹🇿TanzaniaAjanta Pharma Limitedactive
GalvusMet 50/500mg
Film Coated Tablet
🇹🇿TanzaniaNVS Kenya Limitedactive
VILDARIL M 50/1000
Film Coated Tablet
🇹🇿TanzaniaAjanta Pharma Limitedactive
VILDARIL M 50/850
Film Coated Tablet
🇹🇿TanzaniaAjanta Pharma Limitedactive
SciTag Duo 50/1000mg Film-Coated Tablets
Film Coated Tablet
🇹🇿TanzaniaSciGen Pte Ltdactive
SciTag Duo 50/850mg Film-Coated Tablets
Film Coated Tablet
🇹🇿TanzaniaSciGen Pte Ltdactive
VINGLYN M 50/850
Film Coated Tablet
🇹🇿TanzaniaCadila Healthcare Limitedactive
VINGLYN M 50/500
Film Coated Tablet
🇹🇿TanzaniaCadila Healthcare Limitedactive

Vildagliptin And Metformin Hydrochloride in Africa — Regulatory Overview

Vildagliptin And Metformin Hydrochloride is registered across 2 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tanzania, Kenya. AfricaRegulatory refreshes this data daily from official government sources.

Of the 11 registrations, 11 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.